Sanigen
Latest round
- Series B
Last raised
- Jun 2021
Total raised
- $17M
Investors
- 11
About Sanigen
Based in Anyang, South Korea, and founded in 2005, Sanigen develops and provides bacterial whole genome sequencing and rRNA metagenome sequencing services, and bioinformatic analysis for research on comparative genomics, microbiome studies, pathogen detection, and molecular biology. In 2017, the company entered the Next Generation Sequencing or NGS service market and launched the Genelix RT-PCR Detection kit for detecting pathogen bacteria., Ltd. launched Genelix EHEC (VT1, VT2) Duplex RT-PCR and Genelix Rapid DNA extraction kit, and launched Genelix Hepatitis A virus RT-PCR Detection kit in 2019. Genelix 2019-nCoV RT-PCR Detection kit was launched in 2020. The company develops and manufactures Genelix, an RT-PCR diagnostic kit, and various control products that can sterilize and control pathogens and provide next-generation sequencing analysis services including bioinformatics analysis for microorganisms such as viruses, bacteria, and yeast as well as food harmful microorganisms. Sanigen plans to advance the next-generation genetic analysis technology and use it to develop products to release NGS panels with core technology by the second half of 2021.
Who invested in Sanigen
11 investors across 3 rounds
See all investors in Sanigen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sanigen
Who invested in Sanigen?
Sanigen has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sanigen raised?
Sanigen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Sanigen last raise money?
Sanigen's most recent round on record is a Series B, in Jun 2021.
What does Sanigen do?
Based in Anyang, South Korea, and founded in 2005, Sanigen develops and provides bacterial whole genome sequencing and rRNA metagenome sequencing services, and bioinformatic analysis for research on comparative genomics, microbiome studies, pathogen detection, and molecular biology.
Where is Sanigen headquartered?
Sanigen is headquartered in Anyang, South Korea.
Which VCs invest in companies like Sanigen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sanigen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sanigen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.